Rhythm Pharmaceuticals, Inc. (RYTM) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$42,063
Total Return
320.63%
CAGR
33.29%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +6.73% |
| Median | +0.31% |
| Best | +382.94% |
| Worst | -65.20% |
| % of Windows Positive | 50.9% |
1-Year (252 Trading Days)
| Average | +88.62% |
| Median | +79.61% |
| Best | +458.36% |
| Worst | -85.63% |
| % of Windows Positive | 89.4% |
3-Year (756 Trading Days)
| Average | +467.59% |
| Median | +338.62% |
| Best | +1969.77% |
| Worst | +69.50% |
| % of Windows Positive | 100.0% |
Risk Metrics
| Maximum Drawdown | -86.16% |
| Average Drawdown | -25.51% |
| Drawdown Duration | 311 Trading Days |
| Sortino Ratio | 1.25 |
| Calmar Ratio | 0.39 |
| CVaR (5%) | -9.22% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -18.46% (-51.17% ann.) | $1846.04 | $0.00 | $0.00 | $0.00 |
| 2025 | +91.21% | +$9121.12 | $0.00 | $0.00 | $0.00 |
| 2024 | +21.78% | +$2177.50 | $0.00 | $0.00 | $0.00 |
| 2023 | +57.86% | +$5786.40 | $0.00 | $0.00 | $0.00 |
| 2022 | +191.78% | +$19178.38 | $0.00 | $0.00 | $0.00 |
| 2021 | -66.43% | $6643.12 | $0.00 | $0.00 | $0.00 |
| 2020 | +29.49% | +$2948.60 | $0.00 | $0.00 | $0.00 |
| 2019 | -14.58% | $1458.33 | $0.00 | $0.00 | $0.00 |
| 2018 | -7.50% | $750.17 | $0.00 | $0.00 | $0.00 |
| 2017 partial | +18.27% (+113.15% ann.) | +$1827.43 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | October 9, 2017 – February 19, 2020 | -25.36% | -11.64% | $2535.61 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -24.68% | -96.06% | $2467.67 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +59.01% | +110.91% | +$5901.17 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -63.57% | -61.63% | $6356.53 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +148.60% | +162.99% | +$14860.36 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +107.61% | +48.31% | +$10761.42 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | +62.71% | +36.39% | +$6271.44 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.